HN1999000183A - Preparado farmaceuticos de moxifloxacina - Google Patents

Preparado farmaceuticos de moxifloxacina

Info

Publication number
HN1999000183A
HN1999000183A HN1999000183A HN1999000183A HN1999000183A HN 1999000183 A HN1999000183 A HN 1999000183A HN 1999000183 A HN1999000183 A HN 1999000183A HN 1999000183 A HN1999000183 A HN 1999000183A HN 1999000183 A HN1999000183 A HN 1999000183A
Authority
HN
Honduras
Prior art keywords
pharmaceutical preparation
moxifloxacin
relates
preparation
hydrate
Prior art date
Application number
HN1999000183A
Other languages
English (en)
Inventor
Bayer Intellectual Property Gmbh
Original Assignee
Bayer Intellectual Property Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7889824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN1999000183(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Intellectual Property Gmbh filed Critical Bayer Intellectual Property Gmbh
Publication of HN1999000183A publication Critical patent/HN1999000183A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

La invención se refiere a una preparación farmacéutica para administración oral, que contiene moxifloxacino, su sal y / o hidrato, así como la lactosa. La invención se refiere también a un método para la producción de preparación y dijo a su uso para la lucha contra las infecciones bacterianas en el hombre o los animales.
HN1999000183A 1998-11-10 1999-11-01 Preparado farmaceuticos de moxifloxacina HN1999000183A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19855758 1998-11-10

Publications (1)

Publication Number Publication Date
HN1999000183A true HN1999000183A (es) 1999-11-01

Family

ID=7889824

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1999000183A HN1999000183A (es) 1998-11-10 1999-11-01 Preparado farmaceuticos de moxifloxacina

Country Status (41)

Country Link
US (1) US6610327B1 (es)
EP (1) EP1128831B1 (es)
JP (1) JP4809978B2 (es)
KR (1) KR100650489B1 (es)
CN (1) CN1149993C (es)
AR (1) AR021074A1 (es)
AT (1) ATE279193T1 (es)
AU (1) AU745282B2 (es)
BG (1) BG64974B1 (es)
BR (2) BR9915208A (es)
CA (1) CA2349161C (es)
CO (1) CO5070571A1 (es)
CU (1) CU23260B7 (es)
CZ (1) CZ292069B6 (es)
DE (1) DE59910858D1 (es)
DK (1) DK1128831T3 (es)
EE (1) EE04418B1 (es)
ES (1) ES2229786T3 (es)
HK (1) HK1042245B (es)
HN (1) HN1999000183A (es)
HR (1) HRP20010332B1 (es)
HU (1) HU229065B1 (es)
ID (1) ID29089A (es)
IL (2) IL142642A0 (es)
MA (1) MA26757A1 (es)
MY (1) MY121114A (es)
NO (1) NO319342B1 (es)
NZ (1) NZ511554A (es)
PE (1) PE20001304A1 (es)
PL (1) PL194020B1 (es)
PT (1) PT1128831E (es)
RU (1) RU2230555C9 (es)
SI (1) SI1128831T1 (es)
SK (1) SK283936B6 (es)
SV (1) SV1999000194A (es)
TR (1) TR200101310T2 (es)
TW (1) TW580388B (es)
UA (1) UA72483C2 (es)
UY (1) UY25792A1 (es)
WO (1) WO2000027398A1 (es)
ZA (1) ZA200103141B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
WO2005020998A1 (en) * 2003-09-03 2005-03-10 Ranbaxy Laboratories Limited Pharmaceutical compositions of moxifloxacin and processes for their preparation
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
CN1330306C (zh) * 2004-08-11 2007-08-08 深圳市天一时科技开发有限公司 莫西沙星明胶胶囊剂及其制备方法
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
CN100363001C (zh) * 2005-09-21 2008-01-23 深圳市天一时科技开发有限公司 一种莫西沙星胶囊剂及其制备方法
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
BRPI0823092A2 (pt) * 2008-10-09 2015-09-29 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi método de granulação úmida de moxifloxacin anídrico ou seus sais
EP2837376A3 (de) 2008-12-08 2015-03-25 ratiopharm GmbH Kompaktiertes Moxifloxacin
TR200907227A2 (tr) * 2009-09-18 2011-04-21 Bi̇lgi̇ç Mahmut Çözünürlüğü yüksek stabil mikronize granüller.
CN101890169B (zh) * 2009-11-16 2013-09-11 江苏亚邦强生药业有限公司 莫西沙星口服制剂及其制备方法
WO2011086577A2 (en) * 2010-01-12 2011-07-21 Msn Laboratories Limited Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
CN102247313A (zh) * 2010-06-11 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服缓释固体制剂
CN102247314A (zh) * 2011-01-12 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服固体制剂
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
MX2011004759A (es) 2011-05-04 2012-11-21 Senosiain S A De C V Lab Nuevas formas solidas de antibioticos.
RU2466718C1 (ru) * 2011-10-14 2012-11-20 Закрытое акционерное общество "Брынцалов-А" Фармацевтический препарат моксифлоксацина
US9675582B2 (en) 2011-10-25 2017-06-13 U.S. Phytotherapy, Inc. Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
EP2770985A4 (en) 2011-10-25 2015-01-21 U S Phytotherapy Inc ARTEMISININE AND BERBERINE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
US9358261B2 (en) 2011-10-25 2016-06-07 U.S. Phytotherapy, Inc. Additional artemisinin and berberine compositions and methods of making
WO2013063271A1 (en) * 2011-10-25 2013-05-02 U.S. Phytotherapy, Inc. Artemisinin and berberine compositions and methods of making
CN104039322A (zh) * 2011-11-30 2014-09-10 富山化学工业株式会社 含有1-环丙基-8-(二氟甲氧基)-7-[(1r)-1-甲基-2,3-二氢-1h-异吲哚-5-基]-4-氧代-1,4-二氢喹啉-3-羧酸的甲磺酸盐水合物的片剂
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
CN102525982A (zh) * 2012-02-21 2012-07-04 天津市汉康医药生物技术有限公司 一种稳定的盐酸莫西沙星药物组合物
CN102600093B (zh) * 2012-04-11 2013-06-05 南京优科生物医药有限公司 一种莫西沙星片剂及其制备方法
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN103768063B (zh) * 2012-10-19 2016-04-20 深圳信立泰药业股份有限公司 一种盐酸莫西沙星药物组合物及其制备方法
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
WO2015093669A1 (ko) * 2013-12-20 2015-06-25 씨제이헬스케어 주식회사 목시플록사신 수성 제형 및 이의 제조방법
RU2558932C1 (ru) * 2014-05-22 2015-08-10 Открытое Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция моксифлоксацина и способ ее приготовления

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
TW209865B (es) * 1992-01-10 1993-07-21 Bayer Ag
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino

Also Published As

Publication number Publication date
BRPI9915208A (pt) 2001-07-31
JP2002529415A (ja) 2002-09-10
RU2230555C2 (ru) 2004-06-20
HK1042245B (zh) 2005-03-11
HUP0104762A2 (hu) 2002-05-29
CN1325306A (zh) 2001-12-05
SV1999000194A (es) 2000-10-16
NO319342B1 (no) 2005-07-18
CA2349161A1 (en) 2000-05-18
DE59910858D1 (de) 2004-11-18
EE200100259A (et) 2002-12-16
BRPI9915208B1 (pt) 2011-11-01
ID29089A (id) 2001-07-26
CZ20011652A3 (cs) 2001-08-15
BRPI9915208B8 (pt) 2021-07-06
TR200101310T2 (tr) 2001-10-22
KR100650489B1 (ko) 2006-11-28
KR20010089424A (ko) 2001-10-06
NZ511554A (en) 2003-07-25
NO20012248L (no) 2001-06-06
DK1128831T3 (da) 2005-01-17
PT1128831E (pt) 2005-01-31
EP1128831B1 (de) 2004-10-13
ES2229786T3 (es) 2005-04-16
NO20012248D0 (no) 2001-05-07
PE20001304A1 (es) 2000-12-30
ZA200103141B (en) 2002-05-07
WO2000027398A1 (de) 2000-05-18
MA26757A1 (fr) 2004-12-20
HU229065B1 (en) 2013-07-29
IL142642A0 (en) 2002-03-10
PL194020B1 (pl) 2007-04-30
SK283936B6 (sk) 2004-05-04
CU23260B7 (es) 2008-01-24
US6610327B1 (en) 2003-08-26
BR9915208A (pt) 2001-07-31
AU745282B2 (en) 2002-03-21
CN1149993C (zh) 2004-05-19
CO5070571A1 (es) 2001-08-28
HUP0104762A3 (en) 2002-10-28
IL142642A (en) 2006-10-05
BG105459A (en) 2001-12-29
SI1128831T1 (en) 2005-04-30
CZ292069B6 (cs) 2003-07-16
BG64974B1 (bg) 2006-11-30
AR021074A1 (es) 2002-06-12
TW580388B (en) 2004-03-21
UY25792A1 (es) 2001-08-27
HK1042245A1 (en) 2002-08-09
AU1267400A (en) 2000-05-29
EP1128831A1 (de) 2001-09-05
ATE279193T1 (de) 2004-10-15
HRP20010332B1 (en) 2011-01-31
RU2230555C9 (ru) 2006-02-27
MY121114A (en) 2005-12-30
UA72483C2 (en) 2005-03-15
CA2349161C (en) 2008-01-29
EE04418B1 (et) 2005-02-15
HRP20010332A2 (en) 2002-06-30
SK6102001A3 (en) 2001-12-03
PL348112A1 (en) 2002-05-06
JP4809978B2 (ja) 2011-11-09

Similar Documents

Publication Publication Date Title
HN1999000183A (es) Preparado farmaceuticos de moxifloxacina
CU23367A3 (es) Formulación de moxifloxacino con sal común
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
AR037629A1 (es) Formulaciones farmaceuticas que comprenden un derivado de platino
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
ES2195638T3 (es) Preparaciones de combinaciones farmaceuticas en forma solida de dosificacion que contienen cardevilol e hidroclorotiazida.
DE60027575D1 (de) Verwendung von Spinosad oder einer Zusammensetzung enthaltend spinosad
ATE287267T1 (de) Kombinationstherapien mit gefässschädigender aktivität
AR013001A1 (es) Derivados de la piperazina, procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, su utilizacion como medicamentoy el metodo para tratar enfermedades mediadas por la taquinina.
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
UY29445A1 (es) Composiciones para la transmisión transmucosa oral de la metformina
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
BR9913337A (pt) Derivados tan-1057
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
YU87501A (sh) Farmaceutski kompleksi
BRPI0115076B8 (pt) preparação farmacêutica, sua aplicação farmacêutica, bem como processo para preparação da mesma
ES2188232T3 (es) Uso de cetirizina para impedir la aparicion del asma.
ECSP993210A (es) Preparado farmaceutico de moxifloxacina (lea 33327-ec)
ECSP003603A (es) Formulacion de sal comun y moxifloxacina
GT199900194A (es) Preparado farmaceutico de moxifloxacina.
ES2189639B1 (es) Composicion acuosa que contiene acido acetilsalicilico.
SE9803277D0 (sv) Novel compounds
ES2062752T3 (es) Preparado de una sal de oxipurinol en forma oral para el tratamiento de hiperuricemia.